论文部分内容阅读
目的 :了解肺癌肉瘤的临床、病理特点 ,探讨其可能的组织学来源及合理的治疗方式。方法 :对 12例肺癌肉瘤患者的临床资料进行回顾性分析。结果 :所有 12例患者均行手术治疗 ,手术切除率、手术并发症发生率及手术死亡率分别为 10 0 .0 % ,16 .7%和 8.3%。术后 5 a生存率为 33.3% ,已证实死亡的 5例患者除 1例死于术后并发症外 ,其余均死于远处转移。结论 :肺癌肉瘤是一种恶性程度并不高于一般肺癌的恶性肿瘤。手术切除是其首选和主要的治疗手段。手术指征应包括 a期及以早分期、部分 b期及 期患者。
Objective: To understand the clinical and pathological features of lung cancer sarcoma, explore its possible histological sources and reasonable treatment. Methods: The clinical data of 12 patients with lung cancer were analyzed retrospectively. RESULTS: All 12 patients underwent surgical treatment. The rates of surgical resection, surgical complications and operative mortality were 100.0%, 16.7% and 8.3%, respectively. The 5-year survival rate was 33.3%. Five of the 5 confirmed death patients died of distant metastasis except 1 patient died of postoperative complications. Conclusion: Sarcoma of the lung is a malignant tumor whose malignancy is not higher than that of normal lung cancer. Surgery is the first choice and the main treatment. Surgical indications should include a and early staging, some patients with stage b and.